ROCKWELL MEDICAL, INC.
Rockwell Medical, Inc. (Nasdaq: RKMD) operates as a healthcare company specializing in the development, manufacturing, commercialization, and distribution of hemodialysis products for dialysis providers worldwide. The company's website is https://www.rockwellmed.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ROCKWELL MEDICAL, INC. does
In the company’s own words
Rockwell Medical, Inc. (Nasdaq: RKMD) operates as a healthcare company specializing in the development, manufacturing, commercialization, and distribution of hemodialysis products for dialysis providers worldwide. The company's website is https://www.rockwellmed.com.
The company's core business centers on providing liquid and dry acid and bicarbonate concentrates for hemodialysis patients, representing a vital component of end-stage kidney disease treatment. Hemodialysis concentrates are diluted with purified water at dialysis clinics to create dialysate, which removes toxins and balances electrolytes in patients' bloodstreams. Rockwell manufactures its products under current Good Manufacturing Practices regulations at facilities located in Michigan, Texas, and Iowa, with distribution capabilities spanning the United States and select international markets.
Rockwell's product portfolio includes CitraPure citric acid concentrate, Dri-Sate acetic acid concentrate, RenalPure acid and bicarbonate concentrates, SteriLyte bicarbonate concentrate, single-use bicarbonate cartridges, and dry acid concentrate mix systems. The company also distributes ancillary products including acetic acid cleaner, citric acid descaler, and water softener salt pellets. Dialysate concentrates represented one hundred percent of revenue for the fiscal year ended December 31, 2025, with approximately eighty-eight percent of sales directed to the United States market.
Rockwell serves two hundred ninety-four customers, including all five leading dialysis providers in the United States. The company maintains a diverse customer base with most sales concentrations under ten percent, though DaVita accounted for sixteen percent of total net product sales in 2025. International sales represented approximately twelve percent of total sales. The company operates its own transportation subsidiary, Rockwell Transportation, Inc., which maintains a fleet of trucks for product delivery throughout the United States.
The hemodialysis concentrates market in the United States is projected to grow to approximately five hundred sixty million dollars by 2028. Rockwell competes primarily against Fresenius Medical Care NA and Nipro Medical Corporation, positioning itself as the leading supplier of liquid bicarbonate concentrates and one of the largest suppliers of acid and dry bicarbonate concentrates in the United States market.
Company details
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Headquarters
- WIXOM, MI
- Fiscal year end
- December
- CIK
- 1041024
- SIC
- 2834
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ROCKWELL MEDICAL, INC. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · ROCKWELL MEDICAL, INC.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ROCKWELL MEDICAL, INC. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ROCKWELL MEDICAL, INC.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ROCKWELL MEDICAL, INC.'s last four quarterly filings that the numbers alone won't show?”